4D Molecular Therapeutics, Inc.
FDMT
$4.11
-$0.17-3.97%
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | -15.34% | -7.39% | 3.05% | 82.46% | -9.83% |
| Total Receivables | -- | -- | -- | -- | -- |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 13.42% | -17.05% | 10.43% | 15.82% | -2.60% |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | -14.85% | -7.58% | 3.18% | 80.58% | -9.64% |
|
|
|||||
| Total Current Assets | -14.85% | -7.58% | 3.18% | 80.58% | -9.64% |
| Net Property, Plant & Equipment | -2.45% | 41.36% | -3.70% | -3.42% | -3.13% |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 48.78% | 23.45% | 200.91% | 12.72% | 0.29% |
| Total Assets | -7.23% | -2.59% | -1.55% | 85.32% | -6.01% |
|
|
|||||
| Total Accounts Payable | 50.00% | -14.78% | -18.64% | 19.97% | -25.42% |
| Total Accrued Expenses | -11.89% | 67.62% | 41.75% | -24.98% | 17.85% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 10.72% | 59.29% | 0.72% | 0.76% | 0.74% |
| Total Finance Division Other Current Liabilities | 634.29% | -- | -- | -- | 110.00% |
| Total Other Current Liabilities | 634.29% | -- | -- | -- | 110.00% |
| Total Current Liabilities | -1.07% | 51.86% | 18.29% | -13.45% | 4.34% |
|
|
|||||
| Total Current Liabilities | -1.07% | 51.86% | 18.29% | -13.45% | 4.34% |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | -3.92% | 88.75% | -4.89% | -4.55% | -4.23% |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -11.32% | -2.19% | -0.42% | 20.96% | 7.00% |
| Total Liabilities | -2.55% | 60.75% | 8.37% | -8.54% | 1.21% |
|
|
|||||
| Common Stock & APIC | 0.76% | 0.66% | 2.19% | 44.98% | 1.50% |
| Retained Earnings | -9.43% | -9.08% | -7.81% | -7.80% | -8.43% |
| Treasury Stock & Other | -78.78% | 468.26% | -168.81% | -781.25% | -97.00% |
| Total Common Equity | -7.66% | -6.02% | -2.03% | 95.10% | -6.70% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | -7.66% | -6.02% | -2.03% | 95.10% | -6.70% |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | -7.66% | -6.02% | -2.03% | 95.10% | -6.70% |
|
|
|||||
